Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    9028957 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome
Conditions: Autoimmune Disease;   Lymphatic Disease;   Lymphoproliferative Disorder
Intervention: Drug: Pyrimethamine
2 Recruiting Fluorodeoxyglucose Imaging Studies to Detect Lymphoma
Conditions: Autoimmune Lymphoproliferative Syndrome;   Lymphoma
Intervention:
3 Recruiting Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Condition: Primary Immune Deficiency
Intervention:
4 Completed Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
Conditions: Lymphoproliferative Disorders;   Lymphoma
Intervention:

Indicates status has not been verified in more than two years